Dr. Helen Gharwan, MD

Dr. Gharwan practices at Saint Francis Hospital in Hartford, Connecticut, part of Trinity Health.

Dr. Gharwan's NPI, 1770745424, was assigned on June 25, 2008. Dr. Gharwan holds Illinois license 036166286.

Dr. Gharwan's primary practice is Saint Francis Hospital, at 114 Woodland Street & 500 Blue Hills Avenue, Hartford, CT 06105 in Hartford County. The practice phone is (860) 714-5541.

Dr. Gharwan's primary practice is Saint Francis Hospital in Hartford, Connecticut, part of Trinity Health. Dr. Gharwan is also affiliated with DCH Regional Medical Center. The medical group on file is Trinity Health Of New England Medical Group. Dmand AI also links Dr. Gharwan to 5 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gharwan practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Gharwan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Gharwan is licensed in Illinois.

CMS data shows 699 Medicare services from Dr. Gharwan across 5 procedure codes in 2024, for 271 Medicare patients. Medicare paid $59,722 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 271 Medicare patients who saw Dr. Gharwan in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gharwan's median patient age at 71, with 45% women.

In 2024, Dr. Gharwan wrote 273 Medicare Part D claims for 79 patients. 82% of them were for generic drugs. CMS names the drug for 54 of them, across 3 drugs with 11 or more claims each, at $7,194 in total drug cost. In 2023, CMS named 166 claims across 8 drugs.

Dr. Gharwan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Gharwan, published from 2010 to 2016. 2014 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols and Gonadal Steroid Hormones. Dr. Gharwan has published most often in Case Rep Oncol. Dr. Gharwan's most frequent co-authors are Nadia Madelaine Biassou, MD, PhD, Kristen Bunch, DO and Kieron Dunleavy, MD.

CMS Open Payments shows 8 general payments to Dr. Gharwan from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $159.